Journal article
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
Abstract
A 35-year-old female presents with a prolonged activated partial thromboplastin time (aPTT) on routine testing, which is found to be due to a lupus anticoagulant. She has no medical issues, no personal or family history of thrombosis, no history of pregnancy loss, and no symptoms suggestive of an underlying rheumatologic disorder. She is a non-smoker and does not take oral contraceptives. You are asked to provide recommendations regarding the …
Authors
Metjian A; Lim W
Journal
Hematology, Vol. 2009, No. 1, pp. 247–249
Publisher
American Society of Hematology
Publication Date
January 1, 2009
DOI
10.1182/asheducation-2009.1.247
ISSN
1520-4391
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAnticoagulantsAspirinDouble-Blind MethodDrug Therapy, CombinationEvidence-Based MedicineFemaleHumansHydroxychloroquineIncidental FindingsLupus Coagulation InhibitorPartial Thromboplastin TimePractice Guidelines as TopicPrimary PreventionProspective StudiesRandomized Controlled Trials as TopicReference ValuesThromboembolismThrombophiliaUnnecessary Procedures